Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-10

Clinical Trial Update: Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topical amitriptyline and ketamine cream for chemotherapy-induced peripheral neuropathy in cancer patients has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical amitriptyline/ketamine cream (amitriptyline/ketamine)

Snippet

Sponsor: Gary Morrow | Conditions: Neurotoxicity, Pain | Phase 3 | Status: COMPLETED | Results posted: 2015-06-10